Results 1 to 10 of about 25,693 (144)

A Case of M-Type Phospholipase A2 Receptor-Associated Membranous Nephropathy With IgG4-Positive Cells Infiltration in the Interstitium [PDF]

open access: yesClinical Medicine Insights: Case Reports, 2022
A 70-year-old man was referred to our department for evaluation of nephrotic syndrome. Renal biopsy revealed membranous nephropathy (MN). Immunohistochemical analysis demonstrated IgG4-positive staining in the glomeruli and interstitial cells.
Kento Ishibuchi   +9 more
doaj   +5 more sources

Association of M-Type Phospholipase A2 Receptor Deposition in Kidney Tissue with Treatment Outcomes in Patients with Idiopathic Membranous Nephropathy [PDF]

open access: yesJournal of Inflammation Research, 2023
Ning-Qiu Xie,1,* Yu-Lin Zhang,2,* Zi-Li Zheng,1 Quan-Lin Zheng,1 Ruo-Ji Chen1 1Department of Nephrology, Jinjiang Municipal Hospital, Jinjiang, Fujian, 362200, People’s Republic of China; 2Department of Pediatric, Jinjiang Municipal Hospital ...
Xie NQ   +4 more
doaj   +4 more sources

Treatment resistant M-type phospholipase A2 receptor associated membranous nephropathy responds to obinutuzumab: a report of two cases [PDF]

open access: yesBMC Nephrology, 2022
Background Membranous Nephropathy (MN) is a common cause of nephrotic syndrome (NS) in adults. Recognition of MN as an antibody mediated autoimmune disease has enabled the introduction of anti-B-cell therapy.
Rebecca Hudson   +4 more
doaj   +6 more sources

The level and clinical significance of serum soluble M-type phospholipase A2 receptor in patients with primary membranous nephropathy [PDF]

open access: yesRenal Failure
Primary membranous nephropathy (PMN) is a kidney-specific autoimmune glomerular disease, M-type phospholipase A2 receptor (PLA2R1) is the target antigen. However, the level of PLA2R1 in PMN patients serum remains unclear.
Zi-Han Wang   +3 more
doaj   +4 more sources

Presence of M-type Phospholipase A2 Receptor Antibody in Membranous Nephropathy

open access: yesTurkish Journal of Nephrology, 2020
Objective: The presence of autoantibodies against M-type phospholipase A2 receptor (anti-PLA2R) is a characteristic of idiopathic membranous nephropathy (IMN).
Özgür Akın Oto   +7 more
doaj   +2 more sources

Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy [PDF]

open access: yesKidney International Reports, 2020
Introduction: Autoantibodies against the M-type phospholipase A2 receptor (PLA2R) are important markers in the diagnosis and monitoring of primary membranous nephropathy (pMN).
Cornelia Dähnrich   +5 more
doaj   +2 more sources

Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec’s Reference Center [PDF]

open access: yesCanadian Journal of Kidney Health and Disease, 2021
Background: Quantification of the M-type phospholipase A2 receptor antibodies (anti-PLA2R) is now an essential tool for diagnosis and management of primary membranous nephropathy (MN).
Simon Leclerc   +8 more
doaj   +2 more sources

M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. [PDF]

open access: yesClin J Am Soc Nephrol, 2014
Loss of renal function in patients with primary membranous nephropathy cannot be reliably predicted by laboratory or clinical markers at the time of diagnosis. M-type phospholipase A2 receptor autoantibodies have been shown to be associated with changes in proteinuria.
Hoxha E   +4 more
europepmc   +4 more sources

Diagnostic Usefulness of Antibodies Against M-type Phospholipase A2 Receptor (aPLA2R) in Primary Membranous Nephropathy in the Mexican Population. [PDF]

open access: yesCureus, 2023
This study aimed to determine the frequency and diagnostic performance of antibodies against M-type phospholipase A2 receptors (aPLA2R) in subjects with idiopathic membranous nephropathy (IMN).A diagnostic test study was conducted in a cohort of 160 patients from the nephrology outpatient clinic over a period of eight years.
Diaz Garcia JD.
europepmc   +3 more sources

sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor. [PDF]

open access: yesSci Rep, 2014
The M-type phospholipase A2 receptor (PLA2R) is expressed in podocytes in human glomeruli. Group IB secretory phospholipase A2 (sPLA2 IB), which is one of the ligands of the PLA2R, is more highly expressed in chronic renal failure patients than in controls.
Pan Y   +7 more
europepmc   +5 more sources

Home - About - Disclaimer - Privacy